Brainsway Ltd

Stock Chart, Company Information, and Scan Results

$13.46(as of Sep 15, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Brainsway Ltd Company Information, Fundamentals, and Technical Indicators

Stock Price$13.46
Ticker SymbolBWAY
ExchangeNasdaq
SectorHealthcare
IndustryMedical Devices
Employees129
CountyUSA
Market Cap$560.1M

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Brainsway Ltd In Our Stock Scanner

As of Sep 15, 2026
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.